CEACAM5 and COVID-19: In a follow-up study, increased serum CEA may also account for the progression of coronavirus disease 2019 [27], more frequent fracture incidence [28], severity of heart failure (HF), HF adverse prognosis [29], CVD events and all-cause mortality [10].